Societies

It is humbling to present trials that advance care for patients to our colleagues from across the world – SCRI Oncology Partners

Photo taken from SCRI Oncology Partners/LinkedIn

Jun 10, 2024, 10:16

It is humbling to present trials that advance care for patients to our colleagues from across the world – SCRI Oncology Partners

SCRI Oncology Partners recently shared on LinkedIn:

“SCRI Oncology Partners and Sarah Cannon Research Institute physicians just got back from ASCO24.

It is humbling to be able to present data from these trials that advance care for patients to our colleagues from across the world.

It also fills us with gratitude for our patient volunteers on trials that partner with us to make treatments better for tomorrow. It is so exciting that patients can access the newest therapies right here in Nashville!

Across multiple disease subtypes – breast, GI, lung, GU, melanoma, GYN, H&N, and phase I rare tumors we were very encouraged about new afar from this year!”

It is humbling to present trials that advance care for patients to our colleagues from across the world - SCRI Oncology Partners

Source: SCRI Oncology Partners/LinkedIn

ASCO24 Benjamin Garmezy cancer David Spigel Denise Yardley Erika Hamilton LCSM Melissa Johnson Meredith McKean Meredith Sellers Pelster Nashville OncoDaily Oncology Sarah Cannon Research Institute SCRI Oncology Partners

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Agenus and Tanner Pharma Partner to Expand Global Access to BOT/BAL

Special Coverage